Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-05-03
1998-02-24
Jarvis, William R. A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514318, 514333, 514339, A61K 31445, A61K 3144
Patent
active
057212520
ABSTRACT:
This invention provides novel 5-HT.sub.1F agonists which are useful for the treatment of migraine and associated disorders.
REFERENCES:
patent: 3850938 (1974-11-01), Derible et al.
patent: 4359468 (1982-11-01), Freter et al.
patent: 4530932 (1985-07-01), Clemence et al.
patent: 4710500 (1987-12-01), Perregaard
patent: 4742057 (1988-05-01), Ueda et al.
patent: 4997841 (1991-03-01), Oxford et al.
patent: 5001135 (1991-03-01), Oxford et al.
patent: 5017703 (1991-05-01), Matsuo et al.
patent: 5036078 (1991-07-01), Coates
patent: 5045550 (1991-09-01), Jaen
patent: 5066660 (1991-11-01), Oxford et al.
patent: 5118691 (1992-06-01), Jaen et al.
patent: 5187280 (1993-02-01), Jaen et al.
patent: 5216001 (1993-06-01), Perregaard et al.
patent: 5298520 (1994-03-01), Baker et al.
patent: 5317025 (1994-05-01), BruzMagniez
patent: 5322851 (1994-06-01), Perregaard
Tacconi et al. "Indole derivatives" CA 63:13193e (1965).
Wyngaarden et al. "Cecil Textbook of Medicine" Sauders Co., (1983) pp. 1940-1942.
Audia James E.
Nissen Jeffrey S.
Eli Lilly and Company
Jarvis William R. A.
Titus Robert D.
LandOfFree
5HT.sub.1F agonists for the treatment of migraine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5HT.sub.1F agonists for the treatment of migraine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5HT.sub.1F agonists for the treatment of migraine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1875481